Expression of the 67 kDa laminin receptor and the α6 integrin subunit in serous ovarian carcinoma

[1]  R. Reich,et al.  Role of phospholipase D in laminin-induced production of gelatinase A (MMP-2) in metastatic cells , 1995, Clinical & Experimental Metastasis.

[2]  J. Nesland,et al.  Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma – diagnostic and prognostic implications , 2004, Clinical & Experimental Metastasis.

[3]  A. Berner,et al.  EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma , 2004, Clinical & Experimental Metastasis.

[4]  J. Nesland,et al.  Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions , 2004, Clinical & Experimental Metastasis.

[5]  J. Nesland,et al.  High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma , 2004, Clinical & Experimental Metastasis.

[6]  S. Ménard,et al.  The 67 kDa laminin receptor as a prognostic factor in human cancer , 2004, Breast Cancer Research and Treatment.

[7]  N. Weidner,et al.  Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma — results of a multiparametric study , 2004, Breast Cancer Research and Treatment.

[8]  B. Davidson,et al.  αV- and β1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients , 2003 .

[9]  A. Berner,et al.  Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases. , 2002, American journal of clinical pathology.

[10]  David A. Cheresh,et al.  Role of integrins in cell invasion and migration , 2002, Nature Reviews Cancer.

[11]  J. Nesland,et al.  Ets-1 mRNA Expression in Effusions of Serous Ovarian Carcinoma Patients Is a Marker of Poor Outcome , 2001, The American journal of surgical pathology.

[12]  J. Nesland,et al.  Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications. , 2001, Gynecologic oncology.

[13]  J. Nesland,et al.  Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels. , 2001, European journal of cancer.

[14]  J. Nesland,et al.  Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  K. Shiromizu,et al.  Prognostic factors of stage IV epithelial ovarian cancer: a multicenter retrospective study. , 2001, Gynecologic oncology.

[16]  H. Kleinman,et al.  Role of basement membrane in tumor growth and metastasis. , 2001, Surgical oncology clinics of North America.

[17]  J. Nesland,et al.  Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions. , 2001, American journal of clinical pathology.

[18]  R. Weinberg,et al.  Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. , 2001, Experimental cell research.

[19]  Taylor Murray,et al.  Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.

[20]  J. Nesland,et al.  E‐cadherin and α‐, β‐, and γ‐catenin protein expression is up‐regulated in ovarian carcinoma cells in serous effusions , 2000 .

[21]  J. Nesland,et al.  Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions. , 2000, Human pathology.

[22]  K. Mimori,et al.  alpha6 integrin expression in esophageal carcinoma. , 2000, International journal of oncology.

[23]  A. Berner,et al.  Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies , 1999, Virchows Archiv.

[24]  M. Nadji,et al.  Laminin receptor in lymph node negative breast carcinoma , 1999, Cancer.

[25]  K. Yamamoto,et al.  Differential expression of laminin receptors in human hepatocellular carcinoma , 1998, Gut.

[26]  P. Picci,et al.  Adhesion molecules in high-grade soft tissue sarcomas: correlation to clinical outcome. , 1998, European journal of cancer.

[27]  F. Giancotti,et al.  The role of integrins in tumorigenesis and metastasis. , 1998, Cancer investigation.

[28]  S. Ménard,et al.  New insights into the metastasis‐associated 67 kD laminin receptor , 1997, Journal of cellular biochemistry.

[29]  M. Crescenzi,et al.  α6β4 and α6β1 Integrins Associate with ErbB-2 in Human Carcinoma Cell Lines , 1997 .

[30]  S. Ménard,et al.  High‐affinity monomeric 67‐kd laminin receptors and prognosis in pancreatic endocrine tumours , 1997, The Journal of pathology.

[31]  M. Buyse,et al.  Immunocytochemical markers in stage I lung cancer: relevance to prognosis. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  C. Angeletti,et al.  67-Kilodalton laminin receptor expression correlates with worse prognostic indicators in non-small cell lung carcinomas. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  S. Ménard,et al.  Expression of the Mr 67,000 laminin receptor is an adverse prognostic indicator in human thyroid cancer: an immunohistochemical study. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  S. Ménard,et al.  Expression of the 67 kD laminin receptor in human ovarian carcinomas as defined by a monoclonal antibody, MLuC5. , 1996, European journal of cancer.

[35]  R. Bast,et al.  Expression of α6 and β4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin , 1996 .

[36]  L. Mariani,et al.  An I.T.M.O. group study on second-line treatment in advanced epithelial ovarian cancer: an attempt to identify clinical and biological factors determining prognosis. , 1995, European journal of cancer.

[37]  K. Friedrichs,et al.  High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival. , 1995, Cancer research.

[38]  L. Liotta,et al.  Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[39]  R. Bast,et al.  Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas. , 1994, European journal of cancer.

[40]  E. Thomas,et al.  Expression of integrin adhesion molecules in normal ovary and epithelial ovarian tumors , 1993, International Journal of Gynecologic Cancer.

[41]  H. Kleinman,et al.  Altered expression of basement‐membrane components and collagenases in ascitic xenografts of OVCAR‐3 ovarian cancer cells , 1993, International journal of cancer.

[42]  S. Ménard,et al.  Polarization of the α6β4 integrin in ovarian carcinomas , 1993 .

[43]  S. Ménard,et al.  Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. , 1993, Journal of the National Cancer Institute.

[44]  D. Brigati,et al.  Complete one-hour immunocytochemistry based on capillary action. , 1992, BioTechniques.

[45]  L. Liotta,et al.  Laminin receptors, collagenase IV and prognosis in node‐negative breast cancers , 1991, International journal of cancer.

[46]  R. Brentani,et al.  Independent prognostic value of laminin receptor expression in breast cancer survival. , 1990, Cancer research.

[47]  M. Wicha,et al.  Isolation of a cell surface receptor protein for laminin from murine fibrosarcoma cells , 1983, The Journal of cell biology.

[48]  L. Liotta,et al.  Isolation of a tumor cell laminin receptor. , 1983, Biochemical and biophysical research communications.